CC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Chemours Co is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has shown recent price weakness, technical indicators are neutral to bearish, and there are no strong positive catalysts. While analysts have slightly raised price targets, the company's financial performance and ongoing investigations raise concerns. Holding off on buying is recommended until clearer positive signals emerge.
The MACD is negatively expanding, indicating bearish momentum. RSI is at 35.997, which is neutral but nearing oversold territory. Moving averages are converging, showing no clear trend. Key support is at 16.889, with resistance at 19.067. The stock is currently trading closer to its support level.
Analysts have slightly raised price targets, and the company is taking steps to optimize its capital structure by issuing senior notes to reduce debt.
The company is under investigation for potential securities fraud following a significant stock price drop. Financial performance in Q4 2025 showed declining revenue and gross margin, with net income still negative despite improvement. The MACD and RSI indicate bearish momentum, and the stock has underperformed recently.
In Q4 2025, revenue dropped by 4.59% YoY to $1.33 billion. Net income improved but remained negative at -$61 million, up 662.50% YoY. EPS increased to -0.41, up 720% YoY. Gross margin dropped significantly by 40.55% YoY to 11.73%. Overall, financial performance shows mixed signals with ongoing challenges.
Analysts have raised price targets slightly, with most ratings being Neutral or Outperform. The highest price target is $23, while the lowest is $17. Analysts highlight challenges in the company's Titanium Technologies and Advanced Performance Materials segments but acknowledge some improvement in Thermal & Specialized Solutions.
